Literature DB >> 33230923

Evaluation of patient-specific MR distortion correction schemes for improved target localization accuracy in SRS.

Dimitrios Dellios1, Eleftherios P Pappas1, Ioannis Seimenis1, Chryssa Paraskevopoulou2, Kostas I Lampropoulos2, Georgia Lymperopoulou3, Pantelis Karaiskos1,2.   

Abstract

PURPOSE: This work aims at promoting target localization accuracy in cranial stereotactic radiosurgery (SRS) applications by focusing on the correction of sequence-dependent (also patient induced) magnetic resonance (MR) distortions at the lesion locations. A phantom-based quality assurance (QA) methodology was developed and implemented for the evaluation of three distortion correction techniques. The same approach was also adapted to cranial MR images used for SRS treatment planning purposes in single or multiple brain metastases cases.
METHODS: A three-dimensional (3D)-printed head phantom was filled with a 3D polymer gel dosimeter. Following treatment planning and dose delivery, volumes of radiation-induced polymerization served as hypothetical lesions, offering adequate MR contrast with respect to the surrounding unirradiated areas. T1-weighted (T1w) MR imaging was performed at 1.5 T using the clinical scanning protocol for SRS. Additional images were acquired to implement three distortion correction methods; the field mapping (FM), mean image (MI) and signal integration (SI) techniques. Reference lesion locations were calculated as the averaged centroid positions of each target identified in the forward and reverse read gradient polarity MRI scans. The same techniques and workflows were implemented for the correction of contrast-enhanced T1w MR images of 10 patients with a total of 27 brain metastases.
RESULTS: All methods employed in the phantom study diminished spatial distortion. Median and maximum distortion magnitude decreased from 0.7 mm (2.10 ppm) and 0.8 mm (2.36 ppm), respectively, to <0.2 mm (0.61 ppm) at all target locations, using any of the three techniques. Image quality of the corrected images was acceptable, while contrast-to-noise ratio slightly increased. Results of the patient study were in accordance with the findings of the phantom study. Residual distortion in corrected patient images was found to be <0.3 mm in the vast majority of targets. Overall, the MI approach appears to be the most efficient correction method from the three investigated.
CONCLUSIONS: In cranial SRS applications, patient-specific distortion correction at the target location(s) is feasible and effective, despite the expense of longer imaging time since additional MRI scan(s) need to be performed. A phantom-based QA methodology was developed and presented to reassure efficient implementation of correction techniques for sequence-dependent spatial distortion.
© 2020 American Association of Physicists in Medicine.

Entities:  

Keywords:  MRI; SRS; distortion correction; quality assurance; spatial distortion

Year:  2020        PMID: 33230923     DOI: 10.1002/mp.14615

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  3 in total

1.  Evaluation of the ability of the Brainlab Elements Cranial Distortion Correction algorithm to correct clinically relevant MRI distortions for cranial SRT.

Authors:  Paul Retif; Abdourahamane Djibo Sidikou; Christian Mathis; Romain Letellier; Emilie Verrecchia-Ramos; Rémi Dupres; Xavier Michel
Journal:  Strahlenther Onkol       Date:  2022-08-18       Impact factor: 4.033

2.  Geometric distortion assessment in 3T MR images used for treatment planning in cranial Stereotactic Radiosurgery and Radiotherapy.

Authors:  Stefanos Theocharis; Eleftherios P Pappas; Ioannis Seimenis; Panagiotis Kouris; Dimitrios Dellios; Georgios Kollias; Pantelis Karaiskos
Journal:  PLoS One       Date:  2022-05-23       Impact factor: 3.752

3.  Target localization accuracy in frame-based stereotactic radiosurgery: Comparison between MR-only and MR/CT co-registration approaches.

Authors:  Eleftherios P Pappas; Ioannis Seimenis; Panagiotis Kouris; Stefanos Theocharis; Kostas I Lampropoulos; Georgios Kollias; Pantelis Karaiskos
Journal:  J Appl Clin Med Phys       Date:  2022-03-14       Impact factor: 2.243

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.